IA
TLSI icon

IFP Advisors’s TriSalus Life Sciences TLSI Stock Holding History

IFP Advisors’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$232 Buy
+51
New +$203 ﹤0.01% 4835
2025
Q4 		– Sell
-1
Closed -$5 – 5035
2025
Q3 		$5 Buy
+1
New +$5 ﹤0.01% 4807

Other funds holding TLSI

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

IFP Advisors's TLSI Position: Q2 2026 in Review

IFP Advisors opened a new position in TriSalus Life Sciences (TLSI) in Q2 2026: 51 shares worth $232. The stake represents ﹤0.01% of the portfolio and ranks #4835 among its holdings. This is a return to the name: IFP Advisors previously reported a position in TLSI as recently as Q3 2025.

IFP Advisors first reported a position in TLSI in Q3 2025 and has held it in 2 quarters since. 78 funds tracked by Wall St. Rank hold TLSI as of Q2 2026.

  • IFP Advisors held 51 shares of TriSalus Life Sciences worth $232 as of Q2 2026.
  • TriSalus Life Sciences was a new IFP Advisors position in Q2 2026.
  • TriSalus Life Sciences made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #4835 holding.
  • IFP Advisors first reported a position in TriSalus Life Sciences in Q3 2025 and has held it in 2 quarters since.
  • 78 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.